Interview with Emerald Health Therapeutics – VP Talks Pure Sunfarms JV and Expanding Operations

Capital 10X sits down with Emerald Health Therapeutics VP of Finance and Communications Bernie Hertel.

Hertel provides an overview of Emerald Health Therapeutics; a Canadian licensed producer of cannabis products led by a team of life science professionals. He details their “defined dose” approach to developing differentiated products for medical- and adult-use customers.

This is followed by a discussion of the impressive financial results of their Pure SunFarms JV, expanding operations, new c-suite additions, and upcoming catalysts.

0 0 vote
Article Rating

The opinions provided in this article are those of the author and do not constitute investment advice. Readers should assume that the author and/or employees of Capital 10X hold positions in the company or companies mentioned in the article. For more information, please see our Content Disclaimer.

Evan Veryard
Evan Veryard has a Bachelor's of Chemical Engineering from McGill University and a MaSc. of Chemical Engineering from RMC. He has over 6 years of research experience focusing on industrial materials. Address: 682 Indian Road, Toronto, Ontario, M6P 2C9. Phone: 416-721-8257.
Notify of
Inline Feedbacks
View all comments